Reason for post: This article highlights how the antibiotic crisis is primarily a market failure, driven by misaligned incentives and the “antibiotic paradox” rather than a lack of scientific discovery.
It argues for a neoliberal-aligned policy shift toward “pull” incentives, like subscription-based purchasing models and patent extensions, to decouple pharmaceutical profits from sales volume and ensure global health security.
1 Comment
Reason for post: This article highlights how the antibiotic crisis is primarily a market failure, driven by misaligned incentives and the “antibiotic paradox” rather than a lack of scientific discovery.
It argues for a neoliberal-aligned policy shift toward “pull” incentives, like subscription-based purchasing models and patent extensions, to decouple pharmaceutical profits from sales volume and ensure global health security.